The liquid solution from the inventor of Mycofix®
FUMzyme® the only enzyme against fumonisins is now also available for all post-pellet applications.
- Unique, proprietary technology
- Specific in targeting fumonisins
- Irreversible detoxification
FUMzyme® is our breakthrough, patented and registered purified enzyme to biotransform fumonisins into non-toxic metabolites1. Now BIOMIN is offering a revolutionary product, FUMzyme®sol, .suitable for all kinds of liquid applications after treatments at temperatures which could challenge enzyme activity.
1Regulation EU No. 1115/2014, 2017/913 and 2018/1568
FUMzyme®sol was developed to address the new needs of the feed industry. To control feed borne pathogens and to fulfill the needs for special characteristics in terms of pellet shape and consistency, feed is processed under temperatures that can be very challenging for enzymes used to mitigate mycotoxins.
Why do we need an enzyme against fumonisins?
Fumonisins are the second most prevalent mycotoxins worldwide. They undertake synergistic interaction with other mycotoxins and are a problem in animal production.
Unlike aflatoxins and due to their chemical structure, fumonisins cannot be bound by “binders”. The figure below demonstrates the pH dependency of adsorption of fumonisin by different binders on the market:
In vitro and in vivo efficacy
The detoxifying activity of this revolutionary enzyme was confirmed in in vitro and in vivo experiments. FUMzyme® converts 60 ppm fumonisin B1 into the non-toxic metabolite after just 15 minutes.
Certain statements may not be applicable in all geographical regions. Product associated claims may differ based on government requirements.
Product availability may vary by country, please contact BIOMIN for more information.